Select Your Region
LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is an advanced controlled drug release agent form Evonik containing 50 mol % D,L-lactide and 50 mol % Glycolide with no added preservatives. LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 has an inherent viscosity range of 0.15─0.25 dL/g in HFIP and a degradation period of 3 months.
LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is a 100% bioresorbable PLGA-based copolymer available as a white to light tan granule solid pellet with an inherent viscosity of 0.15─0.25 dL/g in HFIP. As part of Evonik's LACTEL® polymer line, it offers exceptional controlled release of pharmaceutical ingredients in long-acting injectable formulations for human generic drug formulations and veterinary medicine with high functionality and advanced metabolization in the body. It offers a cost-effective option, available in small volumes and can be optimized to meet progress requirements. LACTEL® 50:50 DL-PLGA, IV 0.15-0.25 is non-GMO and contains no added preservatives.
Physical state: Solid
Form: Granules
Color: White to light tan
Inherent viscosity (IV) dL/g: 0.15─0.25 (in HFIP)
Degradation time: <3 months
Density (g/mL): 1.34
Tensile Strength (psi): 6000─8000
Elongation (%): 3─10
Modulus (psi): 2─4x10⁵
CAS no. 26780-50-7
Primary Chemistry:
Poly(DL-lactide-co-glycolide)
Human generic drug formulations
Long-acting injectable formulations
Price sensitive applications
veterinary medicine
We’ve detected that you are located in a different region than the region selected on the website. Would you like to change your region?
Current Region: English - United States